Skip to content

Comparison of the effects of ciprofol versus propofol combined with nalbuphine for anesthesia during digestive endoscopy

Comparison of the effects of ciprofol versus propofol combined with nalbuphine for anesthesia during digestive endoscopy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113434
Enrollment
Unknown
Registered
2025-11-28
Start date
2024-12-12
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodynamic fluctuations and the incidence of adverse reactions were observed in ASA class 1-2 patients administered two different groups of anesthetics.

Interventions

Experimental group:Nalbuphine-Ciprofol
Control group:Nalbuphine-Propofol

Sponsors

The Fourth People's Hospital of Shenzhen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients meeting the following criteria were included: indications for painless gastrointes­tinal endoscopy with good tolerance, ASA physical status ?-?, aged 18-65 years (regardless of gender), body mass index 18 kg/m² <= BMI <30 kg/m², and normal hepatic and renal function.

Exclusion criteria

Exclusion criteria: 1. Have a history of allergic reaction to anesthetic drugs or abnormal recovery after anesthesia; 2. Have hypertension, diabetes, hyperlipidemia, or other severe organ dysfunction; 3. Have bradycardia, with a heart rate of less than 50 beats per minute; 4. Have a history of chronic pain and have been taking opioid drugs for a long time; 5. Have functional disorders such as language, hearing, and mental functions; 6. The examination time is more than 30 minutes; 7. Patients considered unsuitable for clinical research by the researchers include those who have had acute respiratory inflammation within 2 weeks and have a history of not recovering, patients with snoring, sleep apnea syndrome, or long-term heavy alcohol consumption.

Design outcomes

Primary

MeasureTime frame
injection pain;The incidence of hypotension;

Secondary

MeasureTime frame
heart rate;bradycardia;respiratory depression;allergy;Physical movement;Narcotrend: Level of Anesthesia Depth and Grade;pharyngeal reflex;bucking;anesthesia duration;muscle twitching;Anesthetic dosage;Blood pressure(SBP DBP MAP);hiccups;

Countries

China

Contacts

Public ContactHu Xiaoli

The Fourth People's Hospital of Shenzhen

805781804@qq.com+86 130 4892 6184

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 26, 2026